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Submandibular gland
siRNASMG) develops through the epithelial–mesenchymal interaction mediated by
many growth/differentiation factors including activin and BMPs, which are synthesized as inactive precursors
and activated by subtilisin-like proprotein convertases (SPC) following cleavage at their R-X-K/R-R site. Here,
we found that Dec-RVKR-CMK, a potent inhibitor of SPC, inhibited the branching morphogenesis of the rat
embryonic SMG, and caused low expression of a water channel AQP5, in an organ culture system. Dec-RVKR-
CMK also decreased the expression of PACE4, a SPC member, but not furin, another SPC member, suggesting
the involvement of PACE4 in the SMG development. Heparin, which is known to translocate PACE4 in the
extracellular matrix into the medium, and an antibody speciﬁc for the catalytic domain of PACE4, both
reduced the branching morphogenesis and AQP5 expression in the SMG. The inhibitory effects of Dec-RVKR-
CMK were partially rescued by the addition of recombinant BMP2, whose precursor is one of the candidate
substrates for PACE4 in vivo. Further, the suppression of PACE4 expression by siRNAs resulted in decreased
expression of AQP5 and inhibition of the branching morphogenesis in the present organ culture system.
These observations suggest that PACE4 regulates the SMG development via the activation of some growth/
differentiation factors.
© 2008 Elsevier Inc. All rights reserved.IntroductionBranching morphogenesis is one of the fundamental develop-
mental processes seen in many glandular tissues during organogen-
esis, and it occurs as a result of epithelial–mesenchymal interactions
(Davies, 2002; Hu and Rosenblum, 2003). Thus, the mature salivary
gland is completed according to the following developmental
scheme: the oral epithelium down-grows into the underlying
mesenchyme to form the salivary bud, which then continually
develops by epithelial cord growth and repeated dichotomous
branching of the distal ends of the epithelial buds (Denny et al.,
1997; Klein, 2002; Melnick and Jaskoll, 2000; Patel et al., 2006;
Tucker, 2007). During this process, the elongated branches differ-
entiate into the ducts, while the terminal epithelial buds become the
acini. Many investigators have analyzed the molecular mechanism of
such salivary branching morphogenesis, and reported the involve-
ment of various growth/differentiation factors in this developmental
process (Patel et al., 2006). Especially, the roles of EGF and FGF family
molecules have been investigated well in the organ culture system
using mouse submandibular gland (SMG) rudiments (De Moerloozesoi).
l rights reserved.et al., 2000; Hoffman et al., 2002; Jaskoll and Melnick, 1999; Jaskoll
et al., 2002; Jaskoll et al., 2004; Jaskoll et al., 2005; Kashimata and
Gresik, 1997; Kashimata et al., 2000; Koyama et al., 2003; Melnick
et al., 2001; Miyazaki et al., 2004; Morita and Nogawa, 1999;
Noguchi et al., 2006; Steinberg et al., 2005; Umeda et al., 2001).
Besides EGF/FGF families, other growth/differentiation factors includ-
ing activin, BMP, IGF, PDGF, and TGFβ have also been shown to play
important roles in the development of the SMG (Ball and Risbridger,
2001; Orr-Urtreger and Lonai, 1992; Roberts and Barth, 1994; Bläuer et
al., 1996; Jaskoll and Melnick, 1999; Jaskoll et al., 2002; Werner and
Katz, 2004). Furue et al. (2001) reported that activin Amay regulate the
salivary acinar differentiation via induction of Sel-1l, which is a
negative regulator of the Notch signaling. Using BMP7-null mice,
Jaskoll et al. (2002) showed the existence of disorganizedmesenchyme
and decreased epithelial branches with fewer lumina in the E17 SMG of
this mutant mice compared with those in its wild-type counterpart.
This ﬁnding suggests the importance of the BMP7 signaling during
embryonic development of the SMG. These TGFβ-related growth/
differentiation factors are synthesized as inactive precursors and are
converted to their mature forms by limited proteolysis atmultiple basic
amino acid sites such as Arg-X-X-Arg and/or Arg-X-Lys/Arg-Arg to
express their biological activities (Constam and Robertson, 1999;
Constam and Robertson, 2000; Cui et al., 1998; Khalil, 1999). It was
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the subtilisin-like proprotein convertase (SPC) family (Seidah et al.,
1994; Rouille et al., 1995), although little is known about the role of
SPCs in SMG development. Recently, we reported that one of SPC
family members, PACE4, is intensely expressed in the prenatal rat
submandibular primordia, although its expression decreases post-
natally (Akamatsu et al., 2007). Disruption of the PACE4 gene
reportedly causes cyclopia, one of the phenotypes of the serious
condition called holoprosencephaly, which shows defects and/or
malformation in craniofacial development including that of the
submaxillary region (Constam and Robertson, 2000). However, the
physiological signiﬁcance of this convertase in SMG development is
still unclear.
On the other hand, saliva secretion is one of the important
physiological functions of salivary glands, and the water channel
AQP5 is known to be involved in this secretion process; i.e., AQP5-null
mice and naturally occurring AQP5 mutant rats show decreased and
viscous hypertonic saliva secretion compared with their wild-type
counterparts (Ma et al., 1999, Murdiastuti et al., 2006). Previously, we
reported that the expression of AQP5 is dramatically increased in the
prenatal SMG in good accordance with the differentiation of the acini
(Akamatsu et al., 2003).
In the present study, therefore, we focused upon the branching
morphogenesis and expression of the water channel AQP5 as
differentiation markers, and analyzed the effects of various protease
inhibitors, antibodies, and siRNAs on rat embryonic SMG rudiments in
the organ culture system to explore the physiological role of PACE4 in
the developing salivary gland.
Materials and methods
Reagents
Monoclonal anti-bone morphogenetic protein-2 and TRI reagent
were purchased from Sigma-Aldrich, Inc. (Saint Louis, Missouri, USA).
Recombinant human BMP2was procured from PeproTech EC (London,
UK). Decanoyl-Arg-Val-Lys-Arg-chloromethylketone was from Alexis
Corporation (Lansen, Switzerland); and Decanoyl-Arg-Val-Arg-Lys-
chloromethylketone, H-D-Phe-Phe-Arg-chloromethylketone, and H-D-
Phe-Pro-Arg-chloromethylketone were purchased from Funakoshi
Co., Ltd. (Tokyo, Japan). Leupeptin was from Peptide Institute, Inc.
(Osaka, Japan), and soybean trypsin inhibitor and heparin were
purchased from Wako Pure Chemical Industries (Osaka, Japan).
Cyclopore™ Track Etched Membrane (0.4, 0.6 μm polycarbonate
clear) was obtained from Whatman (Maidstone, England). Super-
script™/Superscript™ III One-Step RT-PCR System, BGJb medium, and
Oligofectamine were from Invitrogen Corporation (Carlsbad, CA).
Hybond-N+was purchased fromGE Healthcare Bio-Sciences Corp. (NJ,
USA); and DIG Luminescent Detection Kit, from Roche Diagnostics
(Tokyo, Japan). A Historesin Plus kit purchased from Leica Micro-
systems (Heidelberg, Germany) was used.
Animals
Pregnant Sprague–Dawley rats were purchased from Japan SLC
(Hamamatsu, Japan). Animals were kept in our animal facility and
provided water and laboratory chowad libitum. Lighting of the animal
housewas periodically controlled so that it was illuminated during the
period of 0600–1800. The Institutional Review Board of the Animal
Committee of the University of Tokushima approved the protocol
applied for the present animal experiments.
RT-PCR
Total RNA was isolated from the cultured SMG rudiments by using
TRI reagent (Sigma) according to the manufacturer's protocol. RT-PCRwasperformedbyusingSuperScript™/SuperScript™ IIIOne-StepRT-PCR
System (Invitrogen) according to manufacturer's protocol and as
described previously (Akamatsu et al., 2000, Akamatsu et al., 2003). The
primersusedinthisstudywere5′-CCCCAAGGCACCATGAAAAA-3′(sense,
98–117) and 5′-TCACGAATCTCTGAGGTCTG-3′ (antisense,1151–1170) for
AQP5, 5′-CCCTCTGGAACCAAGTCTCAACTT-3′ (sense,1658–1681) and 5′-
TGAAGCCAGCTTTACATCTGCTGC-3′ (antisense, 2676–2699) for PACE4,
5′-TATGGCTACGGGCTGTTGGA-3′ (sense, 1713–1732) and 5′-
CTCGCTGGTATTTTCAATCTCT-3′ (antisense, 2090–2111) for furin, and
5′-ACCCACACTGTGCCCATCTA-3′ (sense, 478–497) and 5′-
CGGAACCGCTCATTGCC-3′ (antisense, 751–767) for β-actin.
Northern blot analysis
RNA samples isolated from the embryonic rat SMGs were
analyzed by Northern blotting as described previously (Akamatsu
et al., 2000; Akamatsu et al., 2003). A 10-μg aliquot of total RNA was
resolved by electrophoresis in a 1% agarose gel containing 6.7%
formaldehyde and transferred onto a nylon membrane, Hybond-N+
(GE Healthcare Bio-Sciences Corp.). The membrane was prehybri-
dized at 68 °C for 4 h with hybridization buffer composed of 2×SSC
(1×SSC is 15 mM sodium citrate containing 0.15 M NaCl, pH 7.2), 50%
formamide, 10% dextran sulfate, and 10 mM dithiothreitol, and then
hybridized with 100 ng/ml of DIG-labeled antisense riboprobe
speciﬁc for rat PACE4A (Akamatsu et al., 2000; Akamatsu et al.,
2007) at 68 °C for 17 h. The membranes were washed with 2×SSC
containing 0.1% SDS at RT, and with 0.1×SSC containing 0.1% SDS at
65 °C. Riboprobe-hybridized PACE4 mRNA was immunologically
detected by using a DIG Luminescent Detection Kit (Roche Diag-
nostics) according to the manufacturer's protocol. DIG-labeled mouse
β-actin antisense cRNA probe (nucleotides 317–989) was used as a
positive control.
Organ culture
Embryos were obtained on day 15.5 of gestation (E15) from their
mother under ether anesthesia. The submandibular primordia were
extracted from E15 embryos under a stereoscopic microscope. The
paired rudiments extracted from an embryo were separately used;
e.g. one for control culture, and the other for the inhibitor
experiment. The SMG rudiments (5±1 rudiments/assay) were placed
on Cyclopore membranes (Whatman) ﬂoated on BGJb medium
(Invitrogen) containing 10% FCS; they were precultured for 1 h
without any additive, and then further cultivated in the presence or
absence of various reagents. Morphological changes that appeared
were photographed at 24–48 h in culture. Total RNA was isolated
from the cultured SMG rudiments, and the expression levels of
PACE4, furin, AQP5, and β-actin were analyzed by RT-PCR as
described above. Mann–Whitney U-test was used for the statistical
analysis of the expression level of PACE4 and AQP5 (Tsumura et al.
2006, Li et al. 2008). For the histological analysis, the SMG
rudiments treated with CMK were ﬁxed for 2 h with ice-cold
modiﬁed Bouin's ﬁxative and were embedded in Historesin Plus as
described previously (Akamatsu et al. 2007, Yao et al. 2006). Then
the tissue sections were cut at 3-μm thickness and stained with 0.1%
toluidine blue O.
RNAi experiment
Various siRNAs for PACE4 were designed and purchased from
iGENE Therapeutics, Inc. (Ibaraki, Japan) and RNAi Co. Ltd. (Tokyo,
Japan). After 1 h of preculture, SMG rudiments were transfected with
siRNAs (0.5 or 1 μg) by using Oligofectamine (Invitrogen) according to
the manufacturer's protocol and to the report of Sakai et al. (2003).
The sequences of sense-strand RNAs for siRNAs used in this study
were summarized in Fig. 7A.
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PACE4 mRNA is abundantly expressed in the prenatal rat submandibular
gland (SMG).
By in situ hybridization, we previously showed the temporospa-
tially regulated expression of a subtilisin-like proprotein convertase,
PACE4, in the developing rat SMG (Akamatsu et al., 2007). PACE4
mRNA was found to be fundamentally expressed in the submandib-
ular epithelia and their derived cell lineages throughout development.
Its expression level was shown to be more intense in the prenatal
glands than in postnatal glands by in situ hybridization. As conﬁrma-
tion of earlier ﬁndings, we conducted RT-PCR and Northern blot
analyses and found that intense expression of PACE4 mRNA occurred
in the prenatal rat SMG, especially in those between E16 and E19,
during which stages the prominent branching morphogenesis
progresses (Fig. 1). Its expression was decreased at E21, immediately
before birth. These observations imply the involvement of PACE4 in
branchingmorphogenesis regulated by various growth/differentiation
factors including members of the TGFβ superfamily.
Suppression of the branching morphogenesis and AQP5 expression in
cultured rat SMG rudiments by decanoyl-Arg-Val-Lys-Arg-
chloromethylketone (Dec-RVKR-CMK)
We ﬁrst analyzed the effects of several protease inhibitors on rat
SMG rudiments in the organ culture system, particularly, to under-
stand the role of the subtilisin-like proprotein convertase PACE4
during the gland development. In this study, we used the culture
system containing the serum. We also used the serum-free system,
but found it difﬁcult to evaluate the expression level of AQP5, a
salivary water channel, because of its low expression (data not
shown). Dec-RVKR-CMK is known to be a potent and useful inhibitor
for the SPC family of proteases. The SMG rudiment cultured in the
presence of Dec-RVKR-CMK (50 μM) showed an obviously suppressed
development of the rudiment as compared with the gland develop-
ment in the presence of FCS only (Fig. 2A). RT-PCR analysis revealed
that the expression of AQP5, which expression is increased in
accordance with the prenatal development of the rat SMG (Akamatsu
et al., 2003), was markedly decreased by this inhibitor (Fig. 2B, lane 5).
Under these conditions, the expression level of one of the SPC family
proteases, PACE4, was also decreased (lane 1); although that of
another member, furin, was not changed remarkably (Fig. 2B, lane 1).
The decrease in the expression level of AQP5 and PACE4 were
statistically signiﬁcant as compared with the control level (Fig. 2C,Fig. 1. Expression of PACE4 mRNA during prenatal development of the rat SMG.
Expression of PACE4 mRNA in the prenatal rat SMG was analyzed by RT-PCR and
Northern blotting as described in the Materials and methods. Total RNAs (each 1 μg)
from rat embryonic SMG were reverse-transcribed and ampliﬁed. The expected size of
RT-PCR product is indicated by an arrowhead with its correct size. Ten-microgram
samples of total RNA from rat embryonic SMGwere analyzed by Northern blotting using
DIG-labeled antisense cRNA probe speciﬁc for PACE4. The arrowhead indicates the
4.4-kb position of mRNA where a single band for PACE4 transcript was detected.
Expression of β-actin is also shown as a positive control. The size markers from a
λDNA-Hind III digest and the position of ribosomal RNAs are shown on the left.pb0.01, n=5). Dimethylsulfoxide, used as vehicle of Dec-RVKR-CMK,
had no inhibitory effects on either the morphological changes or on
the expression of AQP5, PACE4 or furin in the organ culture system
(data not shown). SPC family proteases such as PACE4 and furin belong
to serine protease family and exactly cleave the carboxyl side of the
RVKR sequence, which sequence is also similarly cleaved by trypsin-
like serine proteases. Therefore, we tested if general serine protease
inhibitors, such as leupeptin and soybean trypsin inhibitor, would
show any effect on the SMG development in the same organ culture
system. However, neither leupeptin nor soybean trypsin inhibitor
markedly affected the salivary branching or AQP5 expression (Fig. 2).
For the salivary branching, these two inhibitors rather increased the
number of end buds suggesting the existence of suppressive protease
(s), which also regulates the normal gland development and is
sensitive for these two inhibitors.
Inhibitory effects on the branching morphogenesis and AQP5 expression
are speciﬁcally caused by Dec-RVKR-CMK, but not by Dec-RVRK-CMK,
H-D-FFR-CMK, or H-D-FPR-CMK
In the former experiment, 50 μM Dec-RVKR-CMK suppressed the
expression of PACE4 as well as that of AQP5, but not that of furin,
suggesting that PACE4, rather than furin, may be involved in the
salivary branching. This concentration of Dec-RVKR-CMK is generally
the one used to inhibit furin activity localized at the trans-Golgi
network in the culture cells. To inhibit PACE4 activity localized in the
extracellular matrix, a lower concentration of Dec-RVKR-CMK may be
effective. Therefore, we analyzed the effects of a lower concentration of
Dec-RVKR-CMK. As shown in Fig. 3A, 10 μM Dec-RVKR-CMK in fact
affected the branching morphogenesis of the SMG rudiments; the
rudiments, however, appeared to become swollen as compared with
the ones treated with the 50 μM concentration of this inhibitor.
Further, the expression level of AQP5 was also decreased by 10 μMDec-
RVKR-CMK (Fig. 3B). The decrease in the expression level of AQP5 and
PACE4 were statistically signiﬁcant as compared with the control level
(Fig. 3C, pb0.01, n=5). Although 5 μM Dec-RVKR-CMK also suppressed
the AQP5 expression, the inhibition of the salivary branching was not
so clear at this concentration (data not shown). Based on these results,
we used 10 μMDec-RVKR-CMK thereafter. As we mentioned above, the
SMG rudiments treated with 10 μM Dec-RVKR-CMK seem to become
swollen. We, therefore, analyzed its histology and compared with
those of control and rudiments treated with 50 μM Dec-RVKR-CMK
(Fig. 3D). Although some of end bud of the SMG rudiment treated with
10 μM Dec-RVKR-CMK appeared to be bigger than that treated with
50 μM Dec-RVKR-CMK, their histology looked very similar (Fig. 3D). It
is thought that the difference in the end bud size would be caused by
the proliferation of the epithelial cells.
As a next step, we compared the effect of Dec-RVKR-CMKwith that
of other CMK-type inhibitors to conﬁrm the possible involvement of
PACE4 in the development of SMG rudiments. It is known that the
substrate speciﬁcity of PACE4 is more strict than that of furin and that
Arg-X-Lys/Arg-Arg is the consensus sequence for efﬁcient cleavage by
PACE4. Therefore, we used Dec-RVRK-CMK for a multi basic amino
acid-type inhibitor, and H-D-FFR-CMK and H-D-FPR-CMK for mono-
basic amino acid-type ones. As a result, although they can inhibit
several trypsin-type serine proteases, none of them showed any
inhibitory effects on branching morphogenesis (Fig. 4) or the AQP5
expression level (data not shown) of SMG rudiments in the organ
culture system.
Antibody speciﬁc for the catalytic domain of PACE4 suppresses the
branching morphogenesis and AQP5 expression of SMG rudiments in the
organ culture system
To conﬁrm further the involvement of PACE4 in the development
of cultured SMG rudiments, we analyzed whether an antibody speciﬁc
Fig. 2. Effects of protease inhibitors on the branching morphogenesis and expression of AQP5 and SPCs in rat SMG rudiments in culture. (A) Morphological changes in the cultured
SMG rudiments. SMG rudiments from E15 rat embryos were cultured in the presence of 50 μM Dec-RVKR-chloromethylketone (CMK), 10 μg/ml leupeptin (Leup) or 10 μg/ml
soybean trypsin inhibitor (STI), as described in Materials and methods. Non; a control culture in the absence of any additive. SMG; submandibular gland primordium, SLG;
sublingual gland primordium. (B) Expression of SPCs (PACE4 and furin) and AQP5 mRNAs in the SMG rudiments in culture. The RNA levels were analyzed by RT-PCR after 48 h in
culture in the presence (lanes 1, 5: CMK; lanes 2, 6: Leup; lanes 3, 7: STI) or absence (lanes 4, 8) of protease inhibitors. Lanes 1–4: PACE4 and furin; lanes 5–8: AQP5 and β-actin.
The band intensities for PACE4 and furin (lanes 1–4) or for AQP5 (lanes 5–8) were quantiﬁed by using NIH Image software; and the value is shown above each lane as a relative
amount (the value of each control is regarded as 100%). The expected size of RT-PCR products are indicated on the right, and the size markers from a 100-bp DNA ladder are shown
on the left. (C) Morphological changes and expression levels of PACE4 and AQP5 after 48 h in independent cultures. Lanes 1–4: PACE4; lanes 5–8: AQP5; lanes 1, 5: Non; lanes 2, 6:
CMK; lanes 3, 7: Leu; lanes 4, 8: STI. The mean±SE for 5 independent determinations including the data shown in panel B were analyzed by the Mann–Whitney U-test. ⁎Pb0.01,
signiﬁcantly different from control (Non).
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branching morphogenesis and AQP5 expression in the SMG rudi-
ments. As shown in Fig. 5A, anti-SCD IgG (0.36 mg/ml) suppressed the
increase in the size of the gland seen in the control experiment and
inhibited the gland development in vitro; but the control IgG
(0.36 mg/ml) had no effect at all. By RT-PCR analysis, the expression
level of AQP5 was decreased as well by the treatment with anti-SCD
IgG (53±11.1%, n=3, pb0.05 vs. control level), which changes were not
observed by treatment with the control IgG (Fig. 5B). The expression
level of PACE4 was also decreased signiﬁcantly by the treatment with
anti-SCD IgG (Fig. 5B; 64.7±11.1%, n=3, pb0.05 vs. control level).
It was earlier reported that PACE4, which is generally localized in
the extracellular matrix via its heparin-binding region after the
secretion from its producing cells, is translocated into the medium by
the presence of heparin in the cell culture system (Tsuji et al., 2003).
During the organogenesis, the concentration and activity of morpho-
gens including growth/differentiation factors is spatially and tempo-
rally regulated. It is, therefore, conceivable that the absence of PACE4
in the extracellular matrix of the SMG rudiments fails to activate some
growth/differentiation factor precursor(s) necessary for the develop-
ment of the SMG rudiments in the same matrix. By adding heparin
(0.1 mg/ml) to the organ culture system of SMG rudiments, the
morphological changes in the cultured rudiments was inhibited, a
phenomenon similar to that caused by the addition of anti-SCD IgG(Fig. 5A). Under these conditions, the expression of AQP5 was
suppressed along with that of PACE4 as compared with the control
level (Fig. 5B; for AQP5: 24.3±13.7%, n=3, pb0.05; for PACE4: 28.3±
4.5%, n=3, pb0.05).
The presence of recombinant BMP2 recovers both the Dec-RVKR-CMK-
caused inhibition of branching morphogenesis and decrease in
AQP5 expression
As shown above, the inhibition of PACE4 activity affected not only
branching morphogenesis but also AQP5 expression of SMG rudi-
ments in the organ culture system. These facts suggest that some
growth/differentiation factor(s), which is activated by cleavage by
PACE4 probably at the RVKR or RVRR site(s), is involved in the gland
development. The precursors of BMPs have been shown to be
processed to their mature forms by PACE4 in a cell culture system
(Constam and Robertson, 1999), suggesting these precursors to be
candidate physiological substrates for PACE4. Therefore, we per-
formed a rescue experiment to ﬁnd whether the branching morpho-
genesis and the AQP5 expression suppressed by Dec-RVKR-CMK in the
organ culture system could be recovered by adding recombinant
BMP2.When recombinant BMP2 (50 ng/ml) was added, the branching
morphogenesis was partially rescued (Fig. 6A); whereas the expres-
sion level of AQP5 was recovered to the control level (Fig. 6B; 90.3±
Fig. 3. Effects of a low concentration of Dec-RVKR-CMK on the branching morphogenesis and expression of AQP5 and SPCs in rat SMG rudiments in culture. (A) Morphological
changes in the cultured SMG rudiment. SMG rudiments from E15 rat embryos were cultured in the presence of 50 μM (CMK50) or 10 μM (CMK10) Dec-RVKR-CMK, or in its absence
(Non) as described in Materials and methods. (B) Expression of SPCs (PACE4 and furin) and AQP5 mRNAs in the SMG rudiments. The mRNA levels were analyzed after 48 h in culture
in the presence (lanes 1, 4: 50 μM; lanes 2, 5: 10 μM) or absence (lanes 3, 6) of Dec-RVKR-CMK. Lanes 1–3: PACE4 and furin; lanes 4–6: AQP5 and β-actin. See legend of Fig. 2 for further
explanation of Fig. 3. (C) Morphological changes and expression levels of PACE4 and AQP5 after 48 h in independent cultures. Lanes 1–3: PACE4; lanes 4–6: AQP5; lanes 1, 4: Non;
lanes 2, 5: CMK10; lanes 3, 6: CMK50. The mean±SE for 5 independent determinations including the data shown in panel B were analyzed by the Mann–Whitney U-test. ⁎Pb0.01,
⁎⁎Pb0.02, signiﬁcantly different from respective control (Non). (D) Histology of the cultured SMG rudiments. Left panels are the morphology of the SMG rudiments cultured in the
presence of 50 μM (CMK50) or 10 μM (CMK10) Dec-RVKR-CMK, or in its absence (Non) as described in Materials and methods. Middle panels are their histology stained with 0.1%
toluidine blue O, and the square-enclosed areas in the middle panels are magniﬁed in the right panels, respectively. Bars: 200 μm.
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pb0.05 vs. CMK treated level). We also analyzed the effects of
recombinant BMP4; however, it showed no stimulatory effects on the
branching morphogenesis, and rather showed inhibitory effects (data
not shown), as had been reported by Hoffman et al. (2002). The
involvement of such BMP2 signaling on the branching morphogenesis
and AQP5 expression was further supported by the experiment in
which a monoclonal antibody speciﬁc for BMP2 (10 μg/ml IgG) was
employed: this antibody showed an obvious inhibitory effect in our
organ culture system (Fig. 6; for AQP5, 38.3±10.8%, n=3, pb0.05 vs.
control; for PACE4, 67.3±4.2%, n=3, pb0.05 vs. control). Additionally,
noggin and follistatin, which are antagonists for TGFβ-family ligands
including BMP2, also showed the inhibitory effects on the SMG
morphogenesis and AQP5 expression in our organ culture system
(data not shown).
Transcriptional silencing of PACE4 causes reduced expression of AQP5
and inhibits branching morphogenesis of the cultured SMG rudiments
Finally, we knocked down the expression of PACE4 in the organ
culture system by means of the RNAi method for veriﬁcation of the
involvement of PACE4 in the SMG development. In this study, 4
different siRNAs for PACE4 were used, and the sequences and
corresponding positions of their sense strand are shown in Fig. 7A.Based on the previous report by Sakai et al. (2003), we independently
transfected cultured SMG rudiments with a 500 nM concentration of
each siRNA duplex for PACE4 by using oligofectamine, as described in
the Materials and methods. Under this condition, however, the
expected inhibitory effects on the morphological changes in the
cultured rudiments was not observed clearly (data not shown). RT-
PCR analysis, on the other hand, revealed that the expressions of
PACE4 and AQP5 were suppressed by more than 50% (Fig. 7B, upper
panel). Therefore, we next used 1 μM siRNA duplexes for the
transfection. The transfection with 1 μM siRNA duplexes caused
more effective suppression of the PACE4 expression, and the
expression of AQP5 was suppressed even more efﬁciently (Fig. 7B,
lower panel). Further, the branching morphogenesis of the cultured
SMG rudiments was obviously inhibited under this transfection
condition. As shown in Fig. 7C, indication of the inhibitory effect on
the branching morphogenesis was ﬁrst observed 24 h after transfec-
tion, and the effects became more conspicuous at 48 h after
transfection. As a result, the cultured SMG rudiments showed the
swollen phenotypes with fewer branches, which were similar to that
caused by treatment with Dec-RVKR-CMK shown in Figs. 2 and 3. In
the case of PACE4 siRNA duplex 4-1, which suppressedmost efﬁciently
the expression of both PACE4 and AQP5 in our RNAi experiment (Fig.
7B, lower panel), the submandibular epithelia disappeared by 48 h
after the transfection (Fig. 7C).
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Branching morphogenesis is an important developmental process
in the formation of tree/bush-like structure such as the lung airways,
the kidney collecting ducts, and the excretory epithelia of the
mammary, prostate, and salivary glands (Davies, 2002; Hu and
Rosenblum, 2003; Patel et al., 2006). Ex vivo culture of the salivary
glands has been used as a good model system to understand the
molecular mechanisms of branching morphogenesis; and the involve-
ment of various growth/differentiation factors together with their
receptors in branching morphogenesis of the salivary gland has been
shown in the ex vivo system (Patel et al., 2006). Hitherto, effects of
EGF- and FGF-family molecules have been well analyzed. EGF family
molecules including EGF, TGFα, neuregulin-1, and heparin-binding
EGF-like growth factor (HB-EGF) have been shown to play signiﬁcant
roles in submandibular branching (Jaskoll and Melnick, 1999;
Kashimata and Gresik, 1997; Kashimata et al., 2000; Koyama et al.,
2003; Melnick et al., 2001; Miyazaki et al., 2004; Morita and Nogawa,
1999; Noguchi et al., 2006; Umeda et al., 2001). On the contrary, the
SMG from EGFR-null mice showed no difference from that of wild-
type mice in terms of the maturation level of the terminal buds,
although there was a substantial reduction in the number of the
terminal buds compared with the number for the wild-type (Jaskoll
andMelnick, 1999). Thus it is suggested that the signaling pathway via
EGFR is not essential for the initiation and/or maturation of SMG
development, although it is involved in regulating the number ofFig. 4. Effects of various CMK-type inhibitors (10 μM) on the branching morphogenesis
of rat SMG rudiments in culture. SMG rudiments from E15 rat embryos were cultured in
the presence of 10 μM Dec-RVKR-CMK (RVKR), Dec-RVRK-CMK (RVRK), H-D-FFR-CMK
(FFR) or H-D-FPR-CMK (FPR) as described in Materials and methods. Non; a control
culture in the absence of any inhibitor.
Fig. 5. Effects of anti-SCD antibody and heparin on the branching morphogenesis and
expression of AQP5 and SPCs in rat SMG rudiments in culture. (A) Morphological
changes in the cultured SMG rudiments. The rudiments from E15 rat embryos were
cultured in the presence of anti-SCD antibody (SCD IgG: 0.36 mg/ml), control IgG (cIgG:
0.36 mg/ml) or heparin (Hep: 0.1 mg/ml); and their effects were compared with the
control culture condition (Non). (B) Expression levels of SPCs (PACE4 and furin) and
AQP5 mRNAs. The RNA of the SMG rudiments after 48 h in culture in the presence of
anti-SCD IgG (lanes 3, 6), control IgG (lanes 2, 5), and heparin (lanes 7, 8), or in the
absence of any additive (lanes 1, 4, 9, 10) were analyzed by RT-PCR as described in
Materials and methods. Lanes 1–3, 7, 9: PACE4 and furin; lanes 4–6, 8, 10: AQP5 and β-
actin. See legend of Fig. 2 for further explanation of Fig. 5.branches. In contrast to the signaling via EGF/EGFR, FGF/FGFR
signaling has been shown to play crucial roles in SMG development
based on analyses using ex vivo culture system and KO mice (De
Moerlooze et al., 2000; Hoffman et al., 2002; Jaskoll et al., 2002; Jaskoll
et al., 2004; Jaskoll et al., 2005; Morita and Nogawa, 1999; Steinberg et
al., 2005), although the biologically active form of FGFs is still poorly
deﬁned (Ornitz and Itoh, 2001). Especially, mutant mice heterozygous
for FGF10 and its receptor FGFR2b exhibit hypoplastic SMGs with
fewer ducts and terminal buds, and their null mice exhibit no SMGs,
suggesting that FGF10/FGFR2b signaling plays an essential role in a
dose-dependent manner during SMG branching morphogenesis
(Jaskoll et al., 2005; Entesarian et al., 2005). It is also reported that
FGF10 mutations cause autosomal dominant aplasia of lacrimal and
salivary glands (ALSG) and lacrimo-auriculo-dento-digital (LADD)
syndrome (Entesarian et al., 2005; Milunsky et al., 2006). However,
other growth/differentiation factors such as those of the TGFβ
superfamily, which include TGFβs, BMPs, and activin, have been also
indicated to have important roles in SMG development (Furue et al.,
440 T. Akamatsu et al. / Developmental Biology 325 (2009) 434–4432001; Hoffman et al., 2002; Jaskoll et al., 2002; Jaskoll and Melnick,
1999; Patel et al., 2006; Ritvos et al., 1995). Hoffman et al. (2002)
reported opposite effects of BMP4 and BMP7 on SMG development;
i.e., they found that BMP4 decreases the size and number of epithelial
buds, whereas BMP7 increases the number of buds, suggesting that
the combination of both negative and positive regulatory roles of
various growth/differentiation factors is important in regulating SMG
morphogenesis in vivo. Further, BMP7 can rescue the inhibition of
branchingmorphogenesis of the SMG caused by an inhibitor (SU5402)
of FGFR1 signaling, suggesting that BMP7 is one of the important
regulators of branching and is downstream of FGFR1 signaling
(Hoffman et al., 2002). Additionally, it was reported that the SMG
from BMP7-null embryos showed an abnormal structure with fewer
epithelial branches, less lumen formation, and disorganized mesench-
yme (Jaskoll et al., 2002). In contrast to the uncertainty of the
biologically active form of FGFs, it is now accepted that TGFβ-related
molecules can express their biological activities via the proteolytic
processing at Arg-X-Lys/Arg-Arg site(s) within their inactive precursor
(Constam and Robertson, 1999; Constam and Robertson, 2000; Khalil,Fig. 6. Restoration by BMP2 of CMK-induced inhibition of branching morphogenesis
and expression of AQP5 and SPCs in rat SMG rudiments in culture. (A) Morphological
changes in the cultured SMG rudiments. The rudiments from E15 rat embryos were
cultured in the presence of 10 μM Dec-RVKR-CMK (CMK), 10 μM Dec-RVKR-CMK
together with 50 ng/ml recombinant human BMP2 (CMK+BMP2) or 10 μg/ml anti-
BMP2 IgG (anti-BMP2). Non, control culture condition. (B) Expression of SPCs (PACE4
and furin) and AQP5 mRNAs in the SMG rudiments. The mRNA levels were analyzed by
RT-PCR after 48 h in culture in the presence of CMK (lanes 1, 4), CMK+BMP2 (lanes 2, 5)
or anti-BMP2 (lanes 7, 9) or in the absence of any additive (lanes 3, 6, 8, 10). Lanes 1–3,
7, 8: PACE4 and furin; lanes 4–6, 9, 10: AQP5 and β-actin. See legend of Fig. 2 for further
explanation of Fig. 6.1999). Thus such proteolytic processing is also be important in
regulating SMG development including branching morphogenesis. In
the present study, Dec-RVKR-CMK undoubtedly inhibited the branch-
ing morphogenesis of SMG rudiments in the ex vivo culture. It was
recently reported that Dec-RVKR-CMK also inhibits prostatic budding
and branching, suggesting the involvement of some SPC(s) in prostate
development (Uchida et al., 2007), although the most probable
candidate SPC responsible for prostate development is still unknown.
In our experiments, the inhibitory effects of antibody speciﬁc for the
catalytic domain of PACE4 and siRNAs speciﬁcally designed for PACE4
strongly support the involvement of this convertase in the SMG
development. Among the SPC family, some member plays redundant
roles (Mori et al., 1999); and therefore we also analyzed the
involvement of other SPC members, furin and PC6, which are a
membrane-bound convertase and an ECM-bound convertase like
PACE4, respectively by means of an RNAi experiment. However, at
least 8 candidate siRNAs for furin and 6 candidate siRNAs for PC6,
designed based on the same algorithm used for PACE4 failed to knock
down their individual target genes (Akamatsu et al. unpublished). The
reasonwhy these siRNAs for furin and PC6 failed in the transcriptional
silencing is unclear now, but the transcriptional silencing of PACE4
gene in fact did inhibit the branching morphogenesis of the SMG,
suggesting that neither furin nor PC6 could rescue the lost function of
PACE4 in SMG development.
In addition to growth/differentiation factors, it has been reported
that the extracellular matrix (ECM) also plays important roles in SMG
branching morphogenesis (Davies, 2002; Hardman and Spooner,
1993; Kleinman et al., 2003; Patel et al., 2006). Sakai et al. (2003)
revealed that the focal accumulation of ﬁbronectin at the site of initial
clefts of SMG epithelia is essential for the initiation of epithelial
branching and that the inhibition and transcriptional silencing of
ﬁbronectin decreases cleft formation and inhibits subsequent branch-
ing. Similarly, the accumulation of several members of the collagen
family are observed at the cleft points of the developing mouse
submandibular epithelia, and the collagenase treatment of SMG
rudiments markedly inhibits the branching morphogenesis in ex
vivo cultures (Nakanishi et al., 1988, Fukuda et al., 1988). Collagen
families are also known to be synthesized as inactive precursors and
the proteolytic removal of their N- and/or C-terminal propeptides is
necessary for compatible ﬁbrillogenesis (Imamura et al., 1998, Schäcke
et al., 1998, Unsöld et al., 2002). In the case of pro-α1(V) collagen, its
N-terminal propeptide is processed by BMP1, which is an astacin-like
metalloprotease (Bond and Beynon, 1995; Ge and Greenspan, 2006);
and its C-terminal propeptide is processed by an SPC family protease
(Imamura et al., 1998). Additionally, BMP1 itself is also synthesized as
an inactive precursor and activated by SPC family protease(s) in and
out of cells (Lee et al., 1997; Leighton and Kadler, 2003). In vivo, the
extracellular processing of proBMP1 may be regulated by epithelial–
mesenchymal interactions that affect the production of ECM compo-
nents, as was described by Lee et al. (1997). The present data may
suggest that PACE4 is involved in ECM architecture during the SMG
branching morphogenesis via the proteolytic activation of aforemen-
tioned proproteins of ECM components. Further, heparan sulfates,
which are glycosaminoglycans increasingly produced in accordance
with the progression of submandibular branching and a key regulator
of FGF signaling (Patel et al., 2006; Ornitz and Itoh, 2001), are also
important for branching morphogenesis of the salivary gland. For
example, the removal of heparan sulfates by their degrading enzyme
inhibits salivary branching in ex vivo cultures (Mori et al., 1994;
Nakanishi et al., 1993). Likewise, the addition of exogenous heparin or
heparan sulfate to ex vivo SMG culture inhibits branching morpho-
genesis, as was also shown in the present study, possibly by depriving
the ECM of not only the endogenous heparin-binding growth/
differentiation factors but also PACE4. It has also been reported that
function-blocking antibodies for laminin or peptides from G-domains
of lamininα1 andα5 chains inhibit the salivary branching, suggesting
Fig. 7. Effects of PACE4 siRNAs on expression of AQP5 and SPCs in rat SMG rudiments in culture. (A) Schematic representation of rat PACE4 structure showing the location and
sequence of sense strands of siRNAs (4-1s–4-4s) used in this experiment. (B) Expression of SPCs (PACE4 and furin) and AQP5 mRNAs in the SMG rudiments. The mRNA levels were
analyzed by RT-PCR after 48 h of transfection of siRNAs. Four different siRNAs for PACE4 (4-1: lanes 1, 6; 4-2: lanes 2, 7; 4-3: lanes 3, 8; 4-4: lanes 4, 9) were used for independent
transfection of the SMG rudiments. Lanes 1–5: PACE4 and furin; lanes 6–10: AQP5 and β-actin. See legend of Fig. 2 for further explanation of panel B. (C) Morphological changes in the
cultured SMG rudiments. Effects of siRNAs for PACE4 on the branching morphogenesis of SMG rudiments were analyzed in the organ culture system. SMG rudiments were
independently transfected with 4 different siRNAs (4-1–4-4: 1 μM for each) as described in Materials and methods. Non; a control culture in the absence of any siRNA. Transfection
with 1 μM siRNAs, which suppressed both PACE4 and AQP5 expression efﬁciently, as shown in B, inhibited the salivary branching. The effect of siRNA 4-1 was particularly strong and
salivary epithelia disappeared by 48 h after the transfection.
441T. Akamatsu et al. / Developmental Biology 325 (2009) 434–443the involvement of laminins in the salivary branching (Kadoya et al.,
1995; Kadoya et al., 1997; Kadoya et al., 1998; Kadoya et al., 2003;
Hosokawa et al., 1999). The SMGs from knockout mice of laminin α5
chain seems to be smaller than that of wild-type mice (Patel et al.,
2006; Rebustini et al., 2007). Laminins were also shown to play
important roles in the salivary acinar differentiation (Hoffman et al.,
1996; Hoffman et al., 1998). Hoffman et al. (1996) revealed the roles of
laminin-1 and TGFβ3 in acinar differentiation of HSG cells, which is
the immortalized human submandibular gland cell line derived from
intercalated ductal cells and is known to differentiate into acinar-like
cells on a basement membrane extract gel. Heikinheimo et al. (1999)
reported the participation of BMP6 in human serous acinar differ-
entiation. In our present study, the inhibition of both function and
expression of PACE4 suppressed the branching morphogenesis of
cultured SMG, thus retarding the salivary acinar differentiation. As a
result, the expression of water channel AQP5 involved in saliva
secretion was decreased. These observations together with our
previous study (Akamatsu et al., 2007) suggest the involvement of
PACE4 in salivary acinar differentiation including the transcriptionalactivation of AQP5 via the activation of growth/differentiation factors
such as TGFβ3 and BMP6. The role of PACE4 and transcriptional
regulation of salivary AQP5 in acinar differentiation is now being
investigated.
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